Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Furniture, Fixtures and Other Gross Profit Leases Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Biomerica (BMRA) Shares Issued (2016 - 2026)

Biomerica's Shares Issued history spans 15 years, with the latest figure at $63000.0 for Q1 2026.

On a quarterly basis, Shares Issued fell 96.4% to $63000.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $1.5 million, a 59.57% decrease, with the full-year FY2025 number at $2.1 million, changed N/A from a year prior.
Shares Issued hit $63000.0 in Q1 2026 for Biomerica, down from $493000.0 in the prior quarter.
Over the last five years, Shares Issued for BMRA hit a ceiling of $1.9 million in Q4 2022 and a floor of -$1.9 million in Q1 2023.
Historically, Shares Issued has averaged $584126.6 across 4 years, with a median of $563500.0 in 2022.
The widest YoY moves for Shares Issued: up 707418.8% in 2023, down 393.06% in 2023.
Tracing BMRA's Shares Issued over 4 years: stood at $1.9 million in 2022, then fell by 2.13% to $1.9 million in 2023, then crashed by 73.8% to $493000.0 in 2025, then tumbled by 87.22% to $63000.0 in 2026.
Business Quant data shows Shares Issued for BMRA at $63000.0 in Q1 2026, $493000.0 in Q4 2025, and $939000.0 in Q3 2025.